Role of Perfusion CT in Glioma Grading and Comparison with Conventional MR Imaging Features

References

1. ↵
   Law M, Yang S, Babb JS, et al. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast- enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 2004;25:746–55

   Abstract/FREE Full Text
2. ↵
   Law M, Cha S, Knopp EA, et al. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 2002;222:715–21

   PubMedWeb of Science
3. ↵
   Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumour grade and histologic findings. Radiology 1994;191:41–51

   PubMedWeb of Science
4. ↵
   Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol 1992;3:65–71

   PubMed
5. ↵
   Nugent LJ, Jain RK. Extravascular diffusion in normal and neoplastic tissues. Cancer Res 1984;44:238–44

   Abstract/FREE Full Text
6. ↵
   Jain RK, Gerlowski LE. Extravascular transport in normal and tumor tissues. Crit Rev Oncol Hematol 1986;5:115–70

   PubMed
7. ↵
   Burger PC, Vogel FS. The brain tumors. In: Burger PC, Vogel FS, eds. Surgical Pathology of the Central Nervous System and its Coverings. New York: Wiley;1982 :223–66
8. ↵
   Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999;211:791–98

   CrossRefPubMedWeb of Science
9. ↵
   Wong JC, Provenzale JM, Petrella JR. Perfusion MR imaging of brain neoplasms. AJR Am J Roentgenol 2000;174:1147–57

   PubMed
10. Cha S, Knopp EA, Johnson G, et al. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 2002;223:11–29

    CrossRefPubMedWeb of Science
11. ↵
    Lev MH, Rosen BR. Clinical applications of intracranial perfusion MR imaging. Neuroimaging Clin N Am 1999;9:309–31

    PubMedWeb of Science
12. ↵
    Shin JH, Lee HK, Kwun BD, et al. Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. AJR Am J Roentgenol 2002;179:783–89

    CrossRefPubMed
13. Petrella JR, Provenzale JM. MR perfusion imaging of the brain: techniques and applications. AJR Am J Roentgenol 2000;175:207–19

    CrossRefPubMedWeb of Science
14. ↵
    Law M, Yang S, Wang H, et al. Glioma gradings: specificity and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003;24:1989–98

    Abstract/FREE Full Text
15. ↵
    Sugahara T, Korogi Y, Tomiguchi S, et al. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol 2000;21:901–09

    Abstract/FREE Full Text
16. ↵
    Miles KA, Charnsangavej C, Lee F, et al. Application of CT in the investigation of angiogenesis in oncology. Acad Radiol 2000;7:840–50

    CrossRefPubMed
17. ↵
    Dean BL, Drayer BP, Bird CR, et al. Gliomas: classification with MR imaging. Radiology 1990;174:411–15

    CrossRefPubMedWeb of Science
18. ↵
    Watanabe M, Tanaka R, Takeda N. Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology 1992;34:463–69

    CrossRefPubMedWeb of Science
19. ↵
    Burger PC, Vogel FS, Green SB, et al. Glioblastoma multiforme and anaplastic astrocytoma: pathologic criteria and prognostic implications. Cancer 1985;56:1106–11

    CrossRefPubMedWeb of Science
20. Burger PC. Malignant astrocytic neoplasms: classification, pathologic anatomy, and response to therapy. Semin Oncol 1986;13:16–26

    PubMed
21. ↵
    Burger PC, Scheithauer BW. Tumors of the Central Nervous System. Washington, DC: Armed Forces Institute of Pathology;1994 :452
22. ↵
    Kelly PJ, Daumas-Duport C, Scheithauer BW, et al. Stereotactic histologic correlations of computed tomography and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. Mayo Clin Proc 1987;62:450–59

    CrossRefPubMedWeb of Science
23. ↵
    Jackson RJ, Fuller GN, Abi-Said D, et al. Limitations of stereotactic biopsy in the initial management of gliomas. Neuro-oncol 2001;3:193–200

    Abstract/FREE Full Text
24. ↵
    Gilles FH, Brown WD, Leviton A, et al. Limitations of the World Health Organization classification of childhood supratentorial astrocytic tumor: Children Brain Tumor Consortium. Cancer 2000;88:1477–83

    CrossRefPubMedWeb of Science
25. ↵
    Wesseling P, Ruiter DJ, Burger PC. Angiogenesis in brain tumors: pathobiological and clinical aspects. J Neurooncol 1997;32:253–65

    CrossRefPubMed
26. Johnson JP, Bruce JN. Angiogenesis in human gliomas: prognostic and therapeutic implications. In: Rosen EM, Goldberg D, eds. Regulation of Angiogenesis. Basel, Switzerland: Birkhauser;1997 :29–46
27. ↵
    Lund EL, Spang-Thompsen M, Skovgaard-Poulsen H, et al. Tumor angiogenesis: a new therapeutic target in gliomas. Acta Neurol Scand 1998;97:52–62

    PubMedWeb of Science
28. ↵
    Runge VM, Clanton JA, Price AC, et al. The use of Gd DTPA as a perfusion agent and marker of blood-brain barrier disruption. Magn Reson Imaging 1985;3:43–55

    CrossRefPubMed
29. ↵
    Ginsberg LE, Fuller GN, Hashmi M, et al. The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: histopathological evaluation of a series. Surg Neurol 1998;49:436–40

    CrossRefPubMedWeb of Science
30. Perez-Cruet MJ, Adelman L, Anderson M, et al. CT-guided stereotactic biopsy of nonenhancing brain lesions. Stereotact Funct Neurosurg 1993;61:105–17

    CrossRefPubMed
31. ↵
    Kondziolka D, Lunsford LD, Martinez AJ. Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. J Neurosurg 1993;79:533–36

    PubMedWeb of Science
32. ↵
    Mihara F, Numaguchi Y, Rothman M, et al. Non-contrast-enhancing supratentorial malignant astrocytoma: MR features and possible mechanisms. Radiat Med 1995;13:11–17

    PubMed
33. ↵
    Bagley LJ, Grossman RI, Judy KD, et al. Gliomas: correlation of magnetic susceptibility artifact with histologic grade. Radiology 1997;202:511–16

    PubMed
34. ↵
    Siegal T, Rubinstein R, Tzuk-Shina T, et al. Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow up of brain tumours. J Neurosurg 1997;86:22–27

    PubMedWeb of Science
35. ↵
    Shimizu H, Kumabe T, Tominaga T, et al. Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy. AJNR Am J Neuroradiol 1996;17:737–47

    Abstract
36. Tamiya T, Kinoshita K, Ono Y, et al. Proton magnetic resonance spectroscopy reflects cellular proliferative activity in astrocytomas. Neuroradiology 2000;42:333–38

    CrossRefPubMed
37. Yang D, Korogi Y, Sugahara T, et al. Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI. Neuroradiology 2002;44:656–66

    CrossRefPubMed
38. ↵
    Henry RG, Vigneron DB, Fischbein NJ, et al. Comparison of relative cerebral blood volume and proton spectroscopy in patients with treated gliomas. AJNR Am J Neuroradiol 2000;21:357–66

    Abstract/FREE Full Text
39. ↵
    Jackson A, Kassner A, Annesley-Williams D, et al. Abnormalities in the recirculation phase of contrast agent bolus passage in cerebral gliomas: comparison with relative blood volume and tumor grade. AJNR Am J Neuroradiol 2002;23:7–14

    Abstract/FREE Full Text
40. ↵
    Covarrubias DJ, Rosen BR, Lev MH. Dynamic magnetic resonance perfusion imaging of brain tumors. Oncologist 2004;9:528–37

    Abstract/FREE Full Text
41. ↵
    Cenic A, Nabavi DG, Craen RA, et al. Dynamic CT measurement of cerebral blood flow: a validation study. AJNR Am J Neuroradiol 1999;20:63–73

    Abstract/FREE Full Text
42. Cenic A, Nabavi DG, Craen RA, et al. A CT method to measure hemodynamics in brain tumors: validation and application of cerebral blood flow maps. AJNR Am J Neuroradiol 2000;21:462–70

    Abstract/FREE Full Text
43. ↵
    Nabavi DG, Cenic A, Craen RA, et al. CT assessment of cerebral perfusion: experimental validation and initial clinical experience. Radiology 1999;213:141–49

    PubMedWeb of Science
44. ↵
    Wintermark M, Thiran JP, Maeder P, et al. Simultaneous measurement of regional cerebral blood flow by perfusion CT and stable xenon CT: a validation study. AJNR Am J Neuroradiol 2001;22:905–14

    Abstract/FREE Full Text
45. ↵
    Ding B, Ling HW, Chen KM, et al. Comparison of cerebral blood volume and permeability in preoperative grading of intracranial glioma using CT perfusion imaging. Neuroradiology 2006;48:773–81

    CrossRefPubMed
46. ↵
    Hazle JD, Jackson EF, Schomer DF, et al. Dynamic imaging of intracranial lesions using fast spin-echo imaging: differentiation of brain tumors and treatment effects. J Magn Reson Imaging 1997;7:1084–93

    PubMedWeb of Science
47. ↵
    Bruening R, Wu RH, Yousry TA, et al. Regional relative blood volume MR maps of meningiomas before and after partial embolization. J Comput Assist Tomogr 1998;22:104–10

    CrossRefPubMed
48. ↵
    Hakyemez B, Erdogan C, Ercan I, et al. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging. Clin Radiol 2005;60:493–502

    CrossRefPubMed
49. ↵
    Eastwood JD, Provenzale JM. Cerebral blood flow, blood volume, and vascular permeability of cerebral glioma assessed with dynamic CT perfusion imaging. Neuroradiology 2003;45:373–76

    CrossRefPubMedWeb of Science